发明名称 AT1-RECEPTOR ANTAGONIST FOR PREVENTING AND TREATING POSTISCHEMIC RENAL FAILURE AND FOR PROTECTING ISCHEMIC KIDNEY
摘要 <p><P>PROBLEM TO BE SOLVED: To provide an AT1-receptor antagonist for preventing and treating postischemic renal failure and for protecting ischemic kidneys. <P>SOLUTION: The invention relates to the compound, (S)-N-(1-carboxy-2-methylprop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl)biphenyl-4-yl-methyl]amine (valsartan), of formula (a) or a salt thereof, in particular a pharmaceutically acceptable salt thereof, which can be used for treating acute and chronic postischemic renal failure and for protecting the ischemic kidney. <P>COPYRIGHT: (C)2008,JPO&INPIT</p>
申请公布号 JP2008019273(A) 申请公布日期 2008.01.31
申请号 JP20070258682 申请日期 2007.10.02
申请人 NOVARTIS AG 发明人 HUMKE ULRICH
分类号 A61K45/00;C07D401/10;A61K31/00;A61K31/41;A61K31/415;A61K31/4164;A61K31/4174;A61K31/4178;A61K31/4184;A61K31/4188;A61K31/437;A61K31/44;A61K31/4427;A61K31/443;A61K31/4433;A61K31/4439;A61K31/455;A61K31/47;A61K31/4709;A61K31/472;A61K31/4725;A61P9/10;A61P13/00;A61P13/12;A61P39/00;A61P41/00;A61P43/00;C07D257/04;C07D401/14;C07D403/10;C07D405/06;C07D409/06;C07D471/04 主分类号 A61K45/00
代理机构 代理人
主权项
地址